Does human saliva decrease the antimicrobial activity of chlorhexidine against oral bacteria?

BMC Research Notes

Ali Al-Ahmad²  Elmar Hellwig²  Martin Wolkewitz³  Lamprini Karygianni²  Katja Mahncke²  Christian Hannig¹  Thaer Abouassi² 

[1] Clinic of Operative Dentistry, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany;Department of Operative Dentistry and Periodontology, Albert Ludwigs University, Freiburg, Germany;Institute of Medical Biometry and Medical Informatics, Albert-Ludwigs-University, Freiburg, Germany

关键词: Bacterial count;    Antimicrobial efficacy;    Saliva;    Chlorhexidine (CHX);   

Others  :  1127294
DOI  :  10.1186/1756-0500-7-711

 received in 2014-02-06, accepted in 2014-10-02,  发布年份 2014

【 摘 要 】

Background

Several studies have shown the antibacterial effectiveness of 0.2% chlorhexidine (CHX) in both in vitro and in vivo studies. In this way, CHX comes directly in contact with saliva. This in vitro study aimed at investigating the possible neutralizing effect of saliva on CHX.

Methods

Saliva samples (12 ml) were collected from twenty healthy volunteers. The aerobic and anaerobic bacterial counts in saliva were determined on Colombia blood agar (CBA) and yeast cysteine agar (HCB), respectively. Saliva from each subject was divided among 4 experimental groups (3 ml/group). Samples were centrifuged at 4000 g for 10 min. The centrifuged salivary bacteria were incubated with the following solutions: 0.2% CHX in saliva, CHX in saliva with 7% ethanol, CHX in 0.9% NaCl, CHX in 0.9% NaCl with 7% ethanol. After exposure for 1 min or 3 min to these CHX solutions, the CHX was neutralized and the bacteria were cultivated, after which the number of colony forming units (aerobic and anaerobic) was determined.

Results

CHX reduced the CFU in all groups significantly (p = 0.0001). Therefore, CHX had a similar effect on both aerobic and anaerobic microorganisms. Significantly more bacteria survived the effect of CHX when kept in salivary solution. This effect from saliva could be compensated by the addition of ethanol. In the absence of saliva there was no significant difference observed in the effectiveness of CHX with respect to ethanol. Prolonging the exposure time to 3 min enhanced the effectiveness of CHX.

Conclusions

The effect of saliva on the antimicrobial activity of CHX was weak albeit statistically significant. However, addition of 7% ethanol compensates this effect. The impact of saliva on the reduction of the antimicrobial efficacy of mouthrinses such as CHX needs to be taken into consideration with regard to improving their antibacterial properties.

【 授权许可】

   
2014 Abouassi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Jones CG: Chlorhexidine: is it still the gold standard? Periodontol 2000 1997, 15:55-62.
• [2]Gilbert P, Moore LE: Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005, 99:703-715.
• [3]Spijkervet FK, van Saene JJ, van Saene HK, Panders AK, Vermey A, Fidler V: Chlorhexidine inactivation by saliva. Oral Surg Oral Med Oral Pathol 1990, 69:444-449.
• [4]van der Mei HC, White DJ, Atema-Smit J, van de Belt-Gritter E, Busscher HJ: A method to study sustained antimicrobial activity of rinse and dentifrice components on biofilm viability in vivo. J Clin Periodontol 2006, 33:14-20.
• [5]Ribeiro LG, Hashizume LN, Maltz M: The effect of different formulations of chlorhexidine in reducing levels of mutans streptococci in the oral cavity: A systematic review of the literature. J Dent 2007, 35:359-370.
• [6]Roldan S, Herrera D, Santa-Cruz I, O'Connor A, Gonzalez I, Sanz M: Comparative effects of different chlorhexidine mouth-rinse formulations on volatile sulphur compounds and salivary bacterial counts. J Clin Periodontol 2004, 31:1128-1134.
• [7]Vitkov L, Hermann A, Krautgartner WD, Herrmann M, Fuchs K, Klappacher M, Hannig M: Chlorhexidine-induced ultrastructural alterations in oral biofilm. Microsc Res Tech 2005, 68:85-89.
• [8]Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D: Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol 2001, 28:1127-1136.
• [9]Coessens P, Herrebout F, De Boever JA, Voorspoels J, Remon JP: Plaque-inhibiting effect of bioadhesive mucosal tablets containing chlorhexidine in a 4-day plaque regrowth model. Clin Oral Investig 2002, 6:217-222.
• [10]Attin T, Abouassi T, Becker K, Wiegand A, Roos M, Attin R, A new method for chlorhexidine (CHX) determination: CHX release after application of differently concentrated CHX-containing preparations on artificial fissures. Clin Oral Investig 2008, 12:189-196.
• [11]Jeffcoat MK, Palcanis KG, Weatherford TW, Reese M, Geurs NC, Flashner M: Use of a Biodegradable Chlorhexidine Chip in the Treatment of Adult Periodontitis: Clinical and Radiographic Findings. J Periodontol 2000, 71:256-262.
• [12]Addy M, Moran JM: Clinical indications for the use of chemical adjuncts to plaque control: chlorhexidine formulations. Periodontol 2000 1997, 15:52-54.
• [13]Sekino S, Ramberg P, Uzel NG, Socransky S, Lindhe J: Effect of various chlorhexidine regimens on salivary bacteria and de novo plaque formation. J Clin Periodontol J Clin Periodontol 2003, 30:919-925.
• [14]Garcia-Caballero L, Carmona IT, Gonzalez MC, Posse JL, Taboada JL, Dios PD: Evaluation of the substantivity in saliva of different forms of application of chlorhexidine. Quintessence Int 2009, 40:141-144.
• [15]Portenier I, Haapasalo H, Rye A, Waltimo T, Orstavik D, Haapasalo M: Inactivation of root canal medicaments by dentine, hydroxylapatite and bovine serum albumin. Int Endod J 2001, 34:184-188.
• [16]Matthijs S, Adriaens PA: Chlorhexidine varnishes: a review. J Clin Periodontol 2002, 29:1-8.
• [17]Thomas L, Russell AD, Maillard JY: Antimicrobial activity of chlorhexidine diacetate and benzalkonium chloride against Pseudomonas aeruginosa and its response to biocide residues. J Appl Microbiol 2005, 98:533-543.18.
• [18]Tomás I, García-Caballero L, López-Alvar E, Suárez-Cunqueiro M, Diz P, Seoane J: In situ chlorhexidine substantivity on saliva and plaque-like biofilm: influence of circadian rhythm. J Periodontol 2013, 84:1662-1672.
• [19]Herrera D, Roldan S, Santacruz I, Santos S, Masdevall M, Sanz M: Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol 2003, 30:307-314.
• [20]Cousido MC, Tomás M, Tomás I, Limeres J, García-Caballero L, Diz P: Effect of a neutralising agent on the evaluation of the antimicrobial activity of chlorhexidine on the bacterial salivary flora. Arch Oral Biol 2008, 53:981-984.
• [21]Sheikh W: Development and validation of a neutralizer system for in vitro evaluation of some antiseptics. Antimicrob Agents Chemother 1981, 19:429-434.
• [22]Brown HPR: Normal mixed models. In Applied mixed models in medicine. Edited by Barnett V. Hoboken: Wiley; 1999:33-83.
• [23]Kramer CY: Extension of multiple range tests to group means with unequal number of replications. Biometrics 1956, 1956(12):307-310.
• [24]Zolotukhin S: Metabolic hormones in saliva: origins and functions. Oral Dis 2013, 19:219-229.
• [25]de Almeida PV, Gregio AM, Machado MA, de Lima AA, Azevedo LR: Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008, 9:72-80.
• [26]Portenier I, Waltimo T, Orstavik D, Haapasalo M: Killing of Enterococcus faecalis by MTAD and chlorhexidine digluconate with or without cetrimide in the presence or absence of dentine powder or BSA. J Endod 2006, 32:138-141.
• [27]Veksler AE, Kayrouz GA, Newman MG: Reduction of salivary bacteria by pre-procedural rinses with chlorhexidine 0.12%. J Periodontol 1991, 62:649-651.
• [28]Lampe MF, Ballweber LM, Stamm WE: Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel. Antimicrob Agents Chemother 1998, 42:1726-1730.
• [29]Eldridge KR, Finnie SF, Stephens JA, Mauad AM, Munoz CA, Kettering JD: Efficacy of an alcohol-free chlorhexidine mouthrinse as an antimicrobial agent. J Prosthet Dent 1998, 80:685-690.
• [30]Ehmke B, Moter A, Beikler T, Milian E, Flemmig TF: Adjunctive antimicrobial therapy of periodontitis: long-term effects on disease progression and oral colonization. J Periodontol 2005, 76:749-759.
• [31]Clark DC, Guest JL: The effectiveness of three different strengths of chlorhexidine mouthrinse. J Can Dent Assoc 1994, 60:711-714.
• [32]Ribeiro LG, Hashizume LN, Maltz M: Effect of different 1% chlorhexidine varnish regimens on mutans streptococci levels in saliva and dental biofilm. Am J Dent 2008, 21:295-299.
• [33]Venkatesh Babu NS, Vivek DK, Ambika G: Comparative evaluation of chlorhexidine mouthrinse versus cacao bean husk extract mouthrinse as antimicrobial agents in children. Eur Arch Paediatr Dent 2011, 12:245-249.
• [34]Hannig C, Gaeding A, Basche S, Richter G, Helbig R, Hannig M: Effect of conventional mouthrinses on initial bioadhesion to enamel and dentin in situ. Caries Res 2013, 47:150-161.34.
• [35]Lachenmeier DW, Gumbel-Mako S, Sohnius EM, Keck-Wilhelm A, Kratz E, Mildau G: Salivary acetaldehyde increase due to alcohol-containing mouthwash use: A risk factor for oral cancer. Int J Cancer 2009, 125:730-735.
• [36]Feller L, Chandran R, Khammissa RA, Meyerov R, Lemmer J: Alcohol and oral squamous cell carcinoma. SADJ 2013, 68:176-180.36.
• [37]La Vecchia C: Mouthwash and oral cancer risk: an update. Oral Oncol 2009, 45:198-200.